Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Psychiatry Research
|
October 7, 2003
A brief smell identification test discriminates between deficit and non-deficit schizophrenia
Nora Goudsmit, Eliza Coleman, Regine Anna Seckinger, et al.
Journal of Clinical Pharmacology
|
August 14, 2018
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial
Sanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Archives of General Psychiatry
|
August 4, 2010
Neurobehavioral abnormalities in first-degree relatives of individuals with autism
Matthew W Mosconi, Margaret Kay, Anna-Maria D'Cruz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 13, 2006
The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients
Norah J Shire, Susan D Rouster, Sandra D Stanford, et al.
Nature
|
August 11, 2015
Corrigendum: Bipolar seesaw control on last interglacial sea level
G Marino, E J Rohling, L Rodríguez-Sanz, et al.
The American Journal of Pathology
|
October 30, 2024
Chronic Coinfection with Pseudomonas aeruginosa and Normal Colony Staphylococcus aureus Causes Lung Structural Damage in the Cystic Fibrosis Rat
Gretchen E Bollar, Johnathan D Keith, Denise D Stanford, et al.
Nature
|
June 12, 2015
Bipolar seesaw control on last interglacial sea level
G Marino, E J Rohling, L Rodríguez-Sanz, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
January 22, 2008
Remediation of sleep-deprivation-induced working memory impairment with fMRI-guided transcranial magnetic stimulation
B Luber, A D Stanford, P Bulow, et al.
Journal of Clinical Pharmacology
|
November 27, 2018
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study
Sanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Schizophrenia Bulletin
|
October 28, 2022
Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study
Christoph U Correll, Evan Stein, Christine Graham, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Psychiatry Research
|
October 7, 2003
A brief smell identification test discriminates between deficit and non-deficit schizophrenia
Nora Goudsmit, Eliza Coleman, Regine Anna Seckinger, et al.
Journal of Clinical Pharmacology
|
August 14, 2018
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial
Sanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Archives of General Psychiatry
|
August 4, 2010
Neurobehavioral abnormalities in first-degree relatives of individuals with autism
Matthew W Mosconi, Margaret Kay, Anna-Maria D'Cruz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 13, 2006
The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients
Norah J Shire, Susan D Rouster, Sandra D Stanford, et al.
Nature
|
August 11, 2015
Corrigendum: Bipolar seesaw control on last interglacial sea level
G Marino, E J Rohling, L Rodríguez-Sanz, et al.
The American Journal of Pathology
|
October 30, 2024
Chronic Coinfection with Pseudomonas aeruginosa and Normal Colony Staphylococcus aureus Causes Lung Structural Damage in the Cystic Fibrosis Rat
Gretchen E Bollar, Johnathan D Keith, Denise D Stanford, et al.
Nature
|
June 12, 2015
Bipolar seesaw control on last interglacial sea level
G Marino, E J Rohling, L Rodríguez-Sanz, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
January 22, 2008
Remediation of sleep-deprivation-induced working memory impairment with fMRI-guided transcranial magnetic stimulation
B Luber, A D Stanford, P Bulow, et al.
Journal of Clinical Pharmacology
|
November 27, 2018
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study
Sanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Schizophrenia Bulletin
|
October 28, 2022
Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study
Christoph U Correll, Evan Stein, Christine Graham, et al.
Page
of 10